Groningen, Netherlands

Maarten Leonardus Van Roosmalen

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Maarten Leonardus Van Roosmalen: Innovator in Immunology and Vaccine Development

Introduction

Maarten Leonardus Van Roosmalen is a notable inventor based in Groningen, Netherlands. He has made significant contributions to the fields of immunology and vaccine development. With a total of 2 patents, his work focuses on innovative approaches to vaccine formulation and delivery.

Latest Patents

Van Roosmalen's latest patents include "Immunogenic compositions in particulate form and methods for producing the same." This invention pertains to the development of vaccines based on native antigen oligomers. It provides an immunogenic composition in particulate form, which includes oligomers of a surface-exposed polypeptide of pathogenic or tumor origin. These oligomers are bound non-covalently to a particulate carrier, along with a pharmaceutically acceptable diluent or excipient. Another significant patent is "Bifunctional protein anchors," which relates to bacterial vaccine delivery technology. This technology features built-in immunostimulatory properties, allowing for the immobilization of any antigen of interest without prior modification.

Career Highlights

Throughout his career, Van Roosmalen has worked with various companies, including Applied Nanosystems B.V. and Mucosis B.V. His expertise in immunology has positioned him as a key player in the development of advanced vaccine technologies.

Collaborations

Some of his notable coworkers include Cornelis Johannes Leenhouts and Tjibbe Bosma. Their collaborative efforts have contributed to the advancement of vaccine delivery systems.

Conclusion

Maarten Leonardus Van Roosmalen's innovative work in immunology and vaccine development has led to significant advancements in the field. His patents reflect a commitment to improving vaccine efficacy and delivery methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…